| ![](/images/empty_line.GIF) |
| |
| |
| |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:Q8IX04 | ubiquitin-conjugating enzyme E2 variant 3 (human) | | | ![](/images/empty_line.GIF) | | |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:Q8IX04-2 | ubiquitin-conjugating enzyme E2 variant 3 isoform h2 (human) | | | ![](/images/empty_line.GIF) | | |
| |
| |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:Q8IX04 | ubiquitin-conjugating enzyme E2 variant 3 (human) | | | ![](/images/empty_line.GIF) | | |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:Q8IX04-2 | ubiquitin-conjugating enzyme E2 variant 3 isoform h2 (human) | | | ![](/images/empty_line.GIF) | | |